ChoA Pharmaceutical Co., LTD. (KOSDAQ: 034940)
South Korea
· Delayed Price · Currency is KRW 1,369.00
-15.00 (-1.08%)
Sep 11, 2024, 9:00 AM KST
ChoA Pharmaceutical Co., LTD. Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Operating Revenue | 61,032 | 62,974 | 68,880 | 57,561 | 65,360 | 67,537 | Upgrade
|
| Other Revenue | - | - | - | -0 | - | - | Upgrade
|
| Revenue | 61,032 | 62,974 | 68,880 | 57,561 | 65,360 | 67,537 | Upgrade
|
| Revenue Growth (YoY) | -10.53% | -8.57% | 19.66% | -11.93% | -3.22% | 7.05% | Upgrade
|
| Cost of Revenue | 39,794 | 39,213 | 42,637 | 37,252 | 38,952 | 37,818 | Upgrade
|
| Gross Profit | 21,238 | 23,761 | 26,242 | 20,309 | 26,408 | 29,719 | Upgrade
|
| Selling, General & Admin | 26,756 | 26,439 | 23,940 | 23,785 | 25,179 | 25,669 | Upgrade
|
| Research & Development | 1,988 | 2,182 | 1,302 | 1,422 | 1,542 | 1,685 | Upgrade
|
| Other Operating Expenses | 711.03 | 718.68 | 672.49 | 684.56 | 280.23 | 1,147 | Upgrade
|
| Operating Expenses | 32,426 | 32,552 | 26,725 | 27,311 | 28,264 | 30,127 | Upgrade
|
| Operating Income | -11,188 | -8,792 | -482.21 | -7,003 | -1,856 | -408.36 | Upgrade
|
| Interest Expense | -999.89 | -979.33 | -676.44 | -375.65 | -610.72 | -1,391 | Upgrade
|
| Interest & Investment Income | 258.23 | 246.85 | 215.25 | 246.01 | 125.33 | 147.1 | Upgrade
|
| Earnings From Equity Investments | 18.4 | 19.86 | -4.83 | 17.96 | 11.2 | 10.7 | Upgrade
|
| Currency Exchange Gain (Loss) | 136.39 | -18.38 | 68.8 | 168.44 | 103.87 | 192.99 | Upgrade
|
| Other Non Operating Income (Expenses) | 263.43 | 316.42 | 326.3 | 118.09 | 663.49 | 23.76 | Upgrade
|
| EBT Excluding Unusual Items | -11,511 | -9,206 | -553.13 | -6,828 | -1,563 | -1,425 | Upgrade
|
| Gain (Loss) on Sale of Investments | 59.99 | 66.2 | 1.15 | 342.83 | 594.05 | 218.76 | Upgrade
|
| Gain (Loss) on Sale of Assets | 82.38 | 242.17 | 699.04 | 1,276 | 213.14 | 82.35 | Upgrade
|
| Asset Writedown | -2,032 | -2,036 | -571.44 | -1,938 | -1,012 | -31.82 | Upgrade
|
| Pretax Income | -13,401 | -10,934 | -424.38 | -7,146 | -1,767 | -1,156 | Upgrade
|
| Income Tax Expense | 99.14 | 198.7 | -939.63 | 896.29 | -161.24 | -33.8 | Upgrade
|
| Earnings From Continuing Operations | -13,500 | -11,133 | 515.25 | -8,043 | -1,606 | -1,122 | Upgrade
|
| Minority Interest in Earnings | 610.81 | 618.49 | 45.44 | -1.06 | 287.34 | 216.55 | Upgrade
|
| Net Income | -12,889 | -10,514 | 560.69 | -8,044 | -1,319 | -905.31 | Upgrade
|
| Net Income to Common | -12,889 | -10,514 | 560.69 | -8,044 | -1,319 | -905.31 | Upgrade
|
| Shares Outstanding (Basic) | 31 | 31 | 31 | 31 | 31 | 28 | Upgrade
|
| Shares Outstanding (Diluted) | 31 | 31 | 31 | 31 | 31 | 28 | Upgrade
|
| Shares Change (YoY) | -0.64% | - | - | - | 9.43% | - | Upgrade
|
| EPS (Basic) | -419.49 | -339.39 | 18.10 | -259.64 | -42.57 | -31.98 | Upgrade
|
| EPS (Diluted) | -419.49 | -339.39 | 18.10 | -259.64 | -42.57 | -32.00 | Upgrade
|
| Free Cash Flow | -4,176 | -2,306 | -4,225 | -5,024 | -1,677 | 2,768 | Upgrade
|
| Free Cash Flow Per Share | -135.93 | -74.45 | -136.37 | -162.17 | -54.12 | 97.76 | Upgrade
|
| Gross Margin | 34.80% | 37.73% | 38.10% | 35.28% | 40.40% | 44.00% | Upgrade
|
| Operating Margin | -18.33% | -13.96% | -0.70% | -12.17% | -2.84% | -0.60% | Upgrade
|
| Profit Margin | -21.12% | -16.70% | 0.81% | -13.97% | -2.02% | -1.34% | Upgrade
|
| Free Cash Flow Margin | -6.84% | -3.66% | -6.13% | -8.73% | -2.57% | 4.10% | Upgrade
|
| EBITDA | -8,620 | -6,405 | 1,906 | -4,109 | 1,194 | 2,403 | Upgrade
|
| EBITDA Margin | -14.12% | -10.17% | 2.77% | -7.14% | 1.83% | 3.56% | Upgrade
|
| D&A For EBITDA | 2,568 | 2,387 | 2,388 | 2,893 | 3,050 | 2,811 | Upgrade
|
| EBIT | -11,188 | -8,792 | -482.21 | -7,003 | -1,856 | -408.36 | Upgrade
|
| EBIT Margin | -18.33% | -13.96% | -0.70% | -12.17% | -2.84% | -0.60% | Upgrade
|
| Advertising Expenses | - | 847.87 | 721.26 | 1,114 | 2,376 | 3,126 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.